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ABSTRACT
Background: Niclosamide is a medication used to treat tapeworm infestation in animals and humans. It is also lampricide 
and molluscicide, and can be used in in agriculture as a pesticide. In the treatment of parasitic diseases in fish, niclosamide 
can be used as bath or mixed with the feed. Its most important use in common carp (Cyprinus carpio) is for the treatment 
of Bothriocephalus acheilognathi, which is a very common parasite in this fish species. The aim of this study was to de-
termine the concentrations of niclosamide (NIC) and its metabolite 2-chloro 4-nitro aniline (CNA) and 5-chloro salycilic 
acid (CSA) in the liver and muscles of common carp fingerlings.
Materials, Methods & Results: The fish for the experiment were obtained from Kapetanski Rit fish pond, and were accli-
mated to test conditions at 20.5 ± 1°C. Common carps with an average mass of 60 ± 10 g were treated with niclosamide in 
concentration of 2 g/kg of feed during five consecutive days. The experiment was performed in two treatments: one control 
and niclosamide, in three replications.  Each group contained of 30 fish, in 120 L polyethylene tanks. At the end of the 
treatment, the levels of niclosamide residues were determined using a high performance liquid chromatography (HPLC) 
analysis during over 13 days. The mean values of niclosamide and CNA concentrations in the muscles ranged from 27.7 
µg/kg starting from the first day to <0.5 µg/kg on the 11th day and 14.2 µg/kg from the first day to <1 µg/kg on the 9th day. 
The CSA metabolite in muscles were <1 µg/kg during throughout the entire study. The niclosamide concentration in the 
liver were found to be 51.5 (30.2-61.8) µg/kg the first day and decreased proportionally to <0.5 µg/kg on the13th day. CNA 
level in the liver of treated Common Carps amounted to 170.1 (157-181) µg/kg on the first day and continuously declined 
until the 13th day when recorded values were <1 µg/kg. The CSA concentrations in the liver reached a maximum level of 
11.5 (10.1-12.8) µg/kg on the 7th day and fell to <1 µg/kg on the 13th day.
Discussion: Niclosamide use in fish is questionable, primarily due to the possible toxic effects on some aquatic organisms. 
In Serbia, niclosamide preparation for use in aquaculture, has been produced by Veterinarski zavod Subotica since 1984 
when it was registred for the first time. Niclosamid degradation mechanism showed that the metabolism of niclosamide 
resulted in two main metabolites CNA and CSA. Withdrawal of niclosamide and its residues in the liver and muscle in the 
present investigation lasted from 9 to 13 days. This decrease in residues concentrations is expected and depends primarily 
on several factors such as the length and concentration of drug with which the fish is treated, biotransformation, excretion 
and decomposition of used drug. Niclosamide and CNA were proportionally decreased during the withdrawal time, while 
the CSA value increased to the seventh day although the fish during this period no longer consumed food with niclosamide, 
after which the value then decreased until the end of its elimination. This is also not unexpected because it is known that 
liver and gallbladder is a major organ for collection, storage and elimination of chemical residues. Although the treated 
fish received 2 mg of the niclosamide per g of feed for five consecutive days results obtained in this study indicate that 
the maximal residues concentrations were much lower than doses of niclosamide that each fish absorbed into the body. 
Data obtained during this study provided information about the concentration and withdrawal times of niclosamide and 
its residues CNA and CSA in the liver and muscles of common carp treated orally.
Keywords: niclosamide residues, distribution, common carp, liver, muscles.
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INTRODUCTION
Niclosamide (2’, 5-dichloro-4’-nitrosalicyla-
nilide) is an anthelmintic drug belonging to the sa-
licylanilide structural family [11], which is especially 
effective against cestodes. Niclosamise is used as 
lampricide and molluscicide [1], in agriculture as a 
pesticide, as well as in human and veterinary practices 
[2,5,8,17]. Niclosamide, along with oxyclozanide, was 
found to display “strong in vivo and in vitro activity 
against methicillin-resistant Staphylococcus aureus 
(MRSA)” [13], and suggested that may inhibit Zika 
virus replication in vitro [20]. A number of studies have 
established the anticancer activities of niclosamide and 
have identified it as a potential anticancer agent [9,10]. 
The drug affects tapeworms by uncoupling 
oxidative phosphorylation or stimulation of ATPase 
activity, killing tapeworms on contact [19]. Despite 
its general use, niclosamide is quickly metabolized in 
water and does not exhibit any long-term effects [3].
In the treatment of parasitic diseases in fish, 
niclosamide was used as bath in therapy of some 
monogeneans and was effective in a narrow concen-
tration range of 0.075-0.1 mg/mL (90 min) [15]. It can 
also be used when mixed with the feed in order to 
control cestodes infestation. Its most important use in 
common carp (Cyprinus carpio) is for the treatment 
of Bothriocephalus acheilognathi. Treatment of com-
mon carp with niclosamide (3.4 g/kg in feed) for three 
consecutive days resulted in up to 100% elimination 
of tapeworms [4].
The aim of the present investigation is to 
determine the concentrations and withdrawal period 
of niclosamide residues in the muscles and liver of 
common carp using a high performance liquid chro-
mathography (HPLC).
MATERIALS AND METHODS
Animals and Experiment 
The fish for the experiment were obtained from 
Kapetanski Rit fish pond, and were acclimated to test 
conditions (pH 7.5; 8.1 mg/L as O2; 483 µS/cm as 
electrical conductivity) at 20.5 ± 1°C. Common carp 
(Cyprinus carpio) with an average mass of 60 ± 10 g 
were used. During the study, the fish were divided into 
4 groups of 30 fish, each in 120 L polyethylene tanks 
at the University of Belgrade, Faculty of Agriculture, 
Laboratory of Fish Nutrition. The experiment was per-
formed in two treatments: one control and niclosamide 
(2 g/kg of feed), in three replications. In the study, the 
doses of niclosamide were administered to the fish by 
being mixed with palleted feed for 5 days. The fish 
were fed an amount of food which corresponds to 3% 
of ichtyomasseach day. At the end of the treatment, 
concentrations of niclosamide and its metabolites in 
the muscle and liver were observed over the course 
of 13 days. At each sampling, 3 fish from each tank 
were taken. The physical and chemical properties of 
the water (temperature, oxygen concentration, satu-
ration of water with oxygen, conductivity and pH) 
were measured daily in each tank by multifunctional 
measuring instrument Multi 340i by WTW1 in com-
bination with OxyGuard System2. The behavior of the 
fish in the tanks, food consumption and the possible 
death of the fish were monitored every day. During the 
days when the fish were taken for sampling, the total 
amount of feed from that day on, was corrected to the 
amount of feed that was proportional to the mass of 
the sacrificed fish.
Fish tissue preparation
The control fish meat and liver were frozen 
and stored in plastic containers in the freezer, were 
partially thawed, weighed (about 1 g) and placed into 
Corex 25-mL centrifuge tubes. The meat and liver 
samples (n = 7) and one control were fortified with 1 
mL of a 50 µg/L NIC, CSA and CNA standards using 
a volumetric pipette. The fortified tissue was allowed 
to come in contact with the chemical solution for a 
minimum of 30 min before extraction. Homogenizated 
samples of the meat and liver were extracted with 3 
mL of mobile phase in ultrasonic bath, during 30 min. 
After extraction 1 mL of the raw extract was filtrated 
thought Cronus Syringe Filter Nylon. Clean extracts 
were injected to the HPLC system in a quantity of 10 
µL. Control samples were extracted and cleaned in 
the same way.
HPLC analysis
The HPLC analyses were performed with a 
Thermo Ultimate 3000 model by Thermo Fisher Scien-
tific3 coupled with a photodiode array detector set at 
290 nm and Fluorescence Detector (FLD). The HPLC 
system was controlled by Chromeleon software. The 
mobile phase was pumped at a flow rate of 1 mL/min. 
The column oven was heated at 30ºC. For analysis a 
C18, standard-size HPLC column (4.6 x 250 mm) was 
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used. Niclosamide (98.7%) and CNA (99.3%) were 
purchased from Dr. Ehrenstorfer GmbH4, while CSA 
(98%) was purchased from Sigma Aldrich5. HPLC 
grade Acetonitrile (ACN), Methanol and Phosphoric 
Acid (85%, Wt) were purchased from Fisher Scienti-
fic6. HPLC grade water was used; the water was filtered 
through White membrane filter 0.2 µm, was obtained 
from Lab Logistics Group GmbH7. The mobile phase 
used was acetonitrile–water with the addition of 0.1% 
H3PO4 (60:40) and detection wavelength at 290 nm for 
niclosamide determination. The mobile phase metha-
nol - water with the addition of 0.1% H3PO4 (60:40) 
was used in determining CNA and CSA. Detection 
wavelength at 211 nm was used for CNA determina-
tion, CSA was detected in emission mode in range 
wavelength of 315-470 nm. The stock solution was 
prepared dissolving a 10 mg of NIC, CSA and CNA 
with methanol and amounted to 100 mL. Obtained 
solution was stable at 4ºC for several months.
Method validation 
The method determination of NIC, CSA and 
CNA was a modified method, prepared in accordance 
with ISO 17025. The validation plan included determi-
nation of precision, reproducibility, recovery, linearity, 
limit of detection (LOD) and limit of quantification 
(LOQ) [Table 1]. The meat and liver of the fish without 
treatment were prepared in accordance to validated 
the method. Samples were measured, extracted and 
cleaned up. After that sample were analyzed on the 
HPLC with UV and FLD detectors. Quantitative and 
qualitative analyses were done using Chromeleon 
software. Samples were analyzed in order to not have 
any residues of NIC and its metabolites. Those samples 
were used for internal control and validation study as 
a blank. The precision of the method was evaluated by 
repeatability using the blank fortified with NIC, CSA 
and CNA injected in triplicate (50.0 µg/kg, n = 7). Ex-
traction efficacy was calculated by recovery. Linearity 
of detector was tested in a range of 0.05 to 0.5 µg/kg, 
and was satisfactory in all ranges. LOD was calculated 
as a three standard deviation of baseline noise, while 
LOQ was calculated as a ten standard deviation of the 
baseline noise. The LOD values ranged from 0.5 to 1.1 
µg/kg, and the LOQ varied from 1.5 to 3.7 µg/kg for 
NIC and its metabolites.
Statistical analysis
Data analysis was performed using Statistica 
128 softwareto determine the descriptive statistic pa-
rameters (mean, standard deviation, range).
RESULTS
The results of the distribution of niclosamide 
and its metabolites 2-chloro4-nitro aniline and 5-chlo-
ro salycilic acid in the liver and muscles of common 
carp after the fish were exposed to 20 mg/g of 100% 
niclosamide mixed in the feed during the five-day treat-
ment are shown in Table 2 and Table 3. The results are 
presented as mean concentrations including minimum 
and maximum values. NIC and CNA concentrations 
in the liver of treated common carp were the highest 
on the first day after the treatment and continuously 
declined until the 13th day when the recorded values 
were below the LOD. The CSA values in the liver of 
the common carp increased to the seventh day after the 
Table 1. Average values of precision, reproducibility, accuracy, linearity, LOQ and LOD for NIC, CSA and CAN in meat 
and liver of common carp.
Drug/Metabolite Precision (%) Reproducibility (%) Recovery (%) Linearity (r2)* LOQ (µg/kg) LOD (µg/kg)
Meat
NIC 3.4 14.6 88.1 0.9999 1.6 0.5
CSA 3.6 3.4 98.3 0.9998 3.3 1
CNA 3.5 3.4 94.4 0.9994 3.4 1
Liver
NIC 13.7 15.3 116.3 0.9999 1.5 0.5
CSA 3.5 3.4 94.4 0.9999 3.7 1.1
CNA 7.7 1.8 106.1 0.9994 3.3 1
*r: correlation coefficient. 
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end of treatment, when they reached a maximum value 
of 12.8 µg/kg, after which it started to decrease by the 
end reaching below 1 µg/kg on the13th day.
The concentration of niclosamide and CNA 
in the muscles were lower than in the liver and were 
maintained up to 11 days when the values were be-
low 0.5 µg/kg for niclosamide and on the 9th day 
for CNA, CSA metabolite in muscles were under the 
LOD values.
DISCUSSION
Although niclosamide is used for the treat-
ment of most tapeworm infestations in animals and 
humans, its use in fish is questionable, primarily due 
to the possible toxic effects on some aquatic organisms 
[3,12]. In Serbia, niclosamide preparation for use in 
aquaculture, has been produced by Veterinarski zavod 
Subotica since 1984 when it was registred for the first 
time. Its main indication was to treat Bothriocepha-
lus achelioghnati presents in young cyprinid fishes, 
primarily common carp. In recent years it has been 
withdrawn from the market and since there is no 
effective alternative, it has resulted in it being used 
as an unregistred drug.
Niclosamid degradation mechanism has been 
reported by Rotzinger et al. [14] and Zaazaa et al. 
[21]. They showed that the metabolism of niclosamide 
resulted in two main metabolites CNA and CSA. Me-
tabolism of niclosamide by hydrolysis, reduction, or 
conjugation with glucoronic acid has been reported in 
fish, rats, cestodes, nematodes, mouse and sheep [7].
Withdrawal of niclosamide and its residues 
in the liver and muscle in the present investigation 
lasted from 9 to 13 days. This decrease in residues 
concentrations is expected and depends primarily on 
several factors such as the length and concentration 
of drug with which the fish is treated, biotransforma-
tion, excretion and decomposition of used drug [6]. 
Niclosamide and CNA were proportionally decreased 
during the withdrawal time, while the CSA value 
increased to the seventh day although the fish during 
this period no longer consumed food with niclosa-
mide, after which the value then decreased until the 
end of its elimination. This is also not unexpected 
because it is known that liver and gallbladder is a 
major organ for collection, storage and elimination of 
chemical residues [18]. Similar results were reported 
by Dawson [6] who investigated concentration of 
niclosamide residues in bile of rainbow trout, coho 
salmon, channel catfish and largemouth bass after 
bath exposure. He also recorded an increase in con-
centration of residues in the bile after the fish were 
transferred to clean water and then a slow decrease 
as a result of partly reabsorbtion and recycling from 
bile secreted into the digestive tract.
Table 2. Mean concentrations (µg/kg) of NIC, CNA and CSA in the liver from carp exposed to 2 g/kg of niclosamide for 
selected withdrawal times.
Withdrawal time NIC CNA CSA
X* ± SD** (Ranges) X ± D (Ranges) X ± SD (Ranges)
Control <0.5 <1 <1
Days






























13 <0.5 <1 <1
*X: mean; **SD: standard deviation.
5                                                                                                           B. Kartalović, M. Pucarević, Z. Marković, et al. 2017. Determination of Niclosamide and its Metabolites in Liver and Muscles of 
Common Carp (Cyprinus carpio) Fingerlings. Acta Scientiae Veterinariae. 45: 1490.
Although the treated fish received 2 mg of the 
niclosamide per g of feed for five consecutive days (fish 
weight 60 g consume 3% of ichthyomass a day which 
result in 1.8 g of daily consumed feed or 3.6 mg of niclo-
samide per day i.e 18 mg for five days) results obtained 
in this study indicate that the maximal residues concen-
trations were much lower than doses of niclosamide 
that each fish absorbed into the body. It should be noted 
that the use of niclosamide in carp fingerlings cannot 
have harmful effects on people as potential consumers, 
because this is not older fish aimed for consumption.
There is very little research relating to the 
distribution of niclosamide in fish, especially after oral 
administration of the drug. Schreier et al. [16] developed 
a method that may be used for monitoring niclosamide 
residues in rainbow trout and channel catfish tissues that 
have been exposed to niclosamide lampricide treatments 
or to obtain additional residue chemistry data required 
for reregistration of niclosamide by the EPA. Data ob-
tained during this study provided information about the 
concentration and withdrawal times of niclosamide and 
its residues CNA and CSA in the liver and muscles of 
common carp treated orally.
CONCLUSIONS
Niclosamide residues in common carp liver and 
muscle were successfully determined using the HPLC 
instrument equipped with a UV and FLD detector. Ac-
cording to the presented investigation of concentration 
of niclosamide and its residues in the liver and muscles 
of common carp fingerlings it can be concluded that its 
elimination ends from for 9 to 13 days. However, it is 
necessary to continue to work on studies dealing with 
distribution, elimination and toxicity of niclosamide 
and its metabolites in common carp to justify its use 
in therapy of Bothriocephalus achelioghnati in order 
to renew its registration.
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Table 3. Mean concentrations (µg/kg) of NIC, CNA and CSA in the muscles from carp exposed to 2 g/kg of niclosamide 
for selected withdrawal times.
Withdrawal time NIC CNA CSA
X* ± SD** (Ranges) X ± SD (Ranges) X ± SD (Ranges)
Control <0.5 <1 <1
Days















9 1.2 ± 0.6
(0.5-2.2)
<1 <1
11 <0.5 <1 <1
13 <0.5 <1 <1
*X: mean; **SD: standard deviation.
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